Nasal mucosa biopsy in patients with severe bronchial asthma

I. Malkusova, O. Ruzickova, V. Hrabe, M. Terl, P. Panzner (Pilsen, Czech Republic)

Source: Annual Congress 2009 - Severe asthma and its treatment
Session: Severe asthma and its treatment
Session type: E-Communication Session
Number: 1863
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Malkusova, O. Ruzickova, V. Hrabe, M. Terl, P. Panzner (Pilsen, Czech Republic). Nasal mucosa biopsy in patients with severe bronchial asthma. Eur Respir J 2009; 34: Suppl. 53, 1863

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nasal mucosa biopsy in severe astma patiens as a tool for the prediction of the inflammatory changes in lower airways
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Cytological alterations of bronchial mucosa in 194 smoking patients, suffering from COPD: The importance of endobronchial brushing
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013

Clinically concomitant involvement of upper airways in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 510s
Year: 2004

Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2004167; 10.1183/13993003.04167-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (5) 2000622; 10.1183/13993003.00622-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020
Year: 2020



CCSP modulates inflammation in bronchial epithelium differentiated ex vivo from bronchial biopsy of COPD patients
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


Presence of pulmonary aspiration of sinonasal secretions in patients with chronic cough
Source: Eur Respir J 2002; 20: Suppl. 38, 451s
Year: 2002

Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020


Increased tissue factor in bronchial biopsies from patients with severe asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough
Source: Eur Respir J 2005; 26: Suppl. 49, 479s
Year: 2005

Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Bronchial thermoplatsy in the treatment of bronchial asthma
Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy
Year: 2010

Impact of mepolizumab in severe asthma with nasal polyps
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


The ultrastructure of nasal mucosa in asthmatic children with and without allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 398s
Year: 2005

Bronchial hyperreactivity in children with cough variant of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 473s
Year: 2002

Increased nasal mucosal swelling in subjects with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 427s
Year: 2001

Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 399s
Year: 2003

Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002